European ICU study investigates superbug risk in vulnerable patients
NCT ID NCT06652126
First seen May 20, 2026 · Last updated May 23, 2026 · Updated 1 time
Summary
This study will follow 1,000 critically ill patients in European ICUs to see if those with weakened immune systems (immunocompromised) are more or less likely to pick up or get infected with multidrug-resistant bacteria. Researchers want to confirm earlier findings that isolation measures may protect these patients, which could help guide infection control and antibiotic use. The study is observational, meaning no new treatments are tested—just careful monitoring and data collection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CRITICALLY-ILL PATIENTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
chu de Lille
RECRUITINGLille, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.